from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3140/fadE23

LFCtreatmentdescriptionclass of inhibitor

-0.958

Amikacinug/mL Amikacintranslation

-0.666

Cap5-10ug/mL Capreomycintranslation

-1.493

Rox10-50 ug/mL Roxithromycintranslation

-0.208

SM2-5 ug/mL Streptomycintranslation

-0.772

Tet5-10 ug/mL Tetracyclinetranslation

-0.255

Rif0.2-5ug/mL Rifampicintranscription

-0.139

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.968

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.411

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.139

CPZ10-50 ug/mL Chlorpromazinerespiration

0.923

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.044

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.550

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.903

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.443

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.787

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.663

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.355

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.542

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.649

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.811

Nigericin50 uM Nigericinrespiration

0.057

TRC10-150 ug/mL Triclosanrespiration

0.633

TRZ10-25 ug/mL Thioridazinerespiration

-0.908

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.052

menadione6-10 ug/mL Menadionerespiration

0.536

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.199

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.652

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.145

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.102

NRP_1Non-replicating persistence stage 1dosRassociated

0.181

Amp0.2mg/mL AmpicillincellWall

0.515

Cephalexin20-100 ug/mL CephalexincellWall

-0.631

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.011

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.691

EMB10-20 ug/mL EthambutolcellWall

2.416

Eta12-40 ug/mL EthionamidecellWall

2.270

INH0.2-0.4 ug/mL IsoniazidcellWall

2.409

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.829

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.646

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.166

BZA0.12 mg/mL BenzamidearomaticAmides

-0.707

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.850

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.117

H2O24 mM hydrogen peroxideDNAdamaging

-0.173

Levo10 ug/mL LevofloxacinDNAdamaging

-0.145

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.063

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.190

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.125

UVUV-irradiationDNAdamaging

0.254

ARP41-4 ug/mL Antitubercular compound ARP4?

0.527

Antimycin12.5-50 ug/mL Antimycin A?

-0.866

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.371

PA_110-50 ug/mL Antitubercular compound PA-1?

1.081

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.352

PA8240.2-2 ug/mL PA-824?

1.611

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.076

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.002

Verapamil50 uM Verapamil?

-0.900

mercaptoethanol2 mM 2-Mercaptoethanol?

0.948

methoxatin10-20 ug/mL Methoxatin?